MUCL1 in triple-negative breast cancer: a novel marker associated with the luminal androgen receptor subtype
Franz-Leonard Klaus, Isabella Kitzke, Evelyn Klein, Carolin Mogler, Alexander Muckenhuber · 2026
Read MUCL1 in triple-negative breast cancer: a novel marker associated with the luminal androgen receptor subtype by Franz-Leonard Klaus, Isabella Kitzke, Evelyn Klein, Carolin Mogler, Alexander Muckenhuber (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13088539.txt.
Description
A peer-reviewed research article from Europe PMC (2026). Triple-negative breast cancer (TNBC) comprises several molecularly distinct subtypes. The luminal androgen receptor (LAR) subtype is characterized by AR expression, displays luminal-like gene signatures, and often co-expresses FOXA1 and GCDFP-15, but its immunohistochemical identification remains challenging. Through transcriptomic analyses of GEO datasets, we identified MUCL1 as a candidate marker and validated its protein expression in a retrospective cohort of 106 TNBCs.
Catalog record
| CREATOR | Franz-Leonard Klaus, Isabella Kitzke, Evelyn Klein, Carolin Mogler, Alexander Muckenhuber |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |